Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption
- PMID: 3503911
- DOI: 10.1089/jop.1987.3.159
Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption
Abstract
The primary purpose of this study was to determine the relative contribution of the nasal and the conjunctival mucosae to the systemic absorption of topically applied timolol in the pigmented rabbit. The nasal mucosa was found to be about 2.5 times more efficient than the conjunctival mucosa in contributing to systemic timolol absorption, which occurred to the extent of 74% of the instilled dose. In addition, a minimum of 5-10 min prolongation of ocular contact time was determined to be necessary for significantly reducing systemic drug absorption and indirectly enhancing ocular drug absorption. The pharmaceutical implication of this finding is that ophthalmic vehicles such as polymeric inserts and gels would provide more favorable ocular to systemic drug absorption ratios than vehicles such as aqueous solutions and low-viscosity polymer solutions.
Similar articles
-
Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.Exp Eye Res. 1993 Sep;57(3):341-9. doi: 10.1006/exer.1993.1133. Exp Eye Res. 1993. PMID: 7901046
-
Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol.Exp Eye Res. 1988 Jan;46(1):59-69. doi: 10.1016/s0014-4835(88)80093-9. Exp Eye Res. 1988. PMID: 3342834
-
Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1827-33. Invest Ophthalmol Vis Sci. 1990. PMID: 2211028
-
Review: systemic absorption of topically applied ocular drugs in humans.J Ocul Pharmacol. 1990 Fall;6(3):243-9. doi: 10.1089/jop.1990.6.243. J Ocul Pharmacol. 1990. PMID: 2290070 Review.
-
Delivery of antiglaucoma drugs: ocular vs systemic absorption.J Ocul Pharmacol. 1994 Spring;10(1):349-57. doi: 10.1089/jop.1994.10.349. J Ocul Pharmacol. 1994. PMID: 8207339 Review.
Cited by
-
Partitioning and Spatial Distribution of Drugs in Ocular Surface Tissues.Pharmaceutics. 2021 May 4;13(5):658. doi: 10.3390/pharmaceutics13050658. Pharmaceutics. 2021. PMID: 34064499 Free PMC article.
-
Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.Pharm Res. 1991 Sep;8(9):1166-74. doi: 10.1023/a:1015810619869. Pharm Res. 1991. PMID: 1788163
-
Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma.J Drug Assess. 2021 Aug 23;10(1):91-96. doi: 10.1080/21556660.2021.1967642. eCollection 2021. J Drug Assess. 2021. PMID: 34447609 Free PMC article.
-
Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.Pharm Res. 1994 Sep;11(9):1278-82. doi: 10.1023/a:1018938310628. Pharm Res. 1994. PMID: 7816756
-
Influence of format on in vitro penetration of antibody fragments through porcine cornea.Br J Ophthalmol. 2005 Sep;89(9):1205-9. doi: 10.1136/bjo.2005.066225. Br J Ophthalmol. 2005. PMID: 16113383 Free PMC article.